Ethylene Glycol

Ethylene Glycol

SCHEMBL7141967

CC(=O)CCCN1C(=O)c2ccccc2C1=O.OCCO

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.55
ACHE P22303 1/20 0.55
KMT2A Q03164 4/20 0.55
HSD17B10 Q99714 2/20 0.55
MEN1 O00255 1/20 0.55
HDAC8 Q9BY41 3/20 0.54
HDAC3 O15379 2/20 0.54
HDAC4 P56524 2/20 0.54
HDAC1 Q13547 2/20 0.54
HDAC7 Q8WUI4 2/20 0.54
HDAC2 Q92769 2/20 0.54
HDAC10 Q969S8 2/20 0.54
HDAC11 Q96DB2 2/20 0.54
HDAC6 Q9UBN7 2/20 0.54
HDAC9 Q9UKV0 2/20 0.54
HDAC5 Q9UQL6 2/20 0.54
LMNA P02545 1/20 0.52
TDP1 Q9NUW8 1/20 0.51
HPGD P15428 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2084857 0.95 ALDH1A1 (0.59) ALDH1A1ACHEKMT2AHSD17B10MEN1
SCHEMBL29740524 0.95 ALDH1A1 (0.59) ALDH1A1ACHEKMT2AHSD17B10MEN1
Ethylene SCHEMBL9101813 0.92 ALDH1A1 (0.56) ALDH1A1ACHEKMT2AHSD17B10MEN1
SCHEMBL7443883 0.90 HDAC8 (0.65) ALDH1A1ACHEKMT2AHSD17B10MEN1
SCHEMBL10913404 0.89 HDAC8 (0.68) ALDH1A1KMT2AMEN1HDAC8HDAC3
SCHEMBL10495286 0.89 HDAC8 (0.68) ALDH1A1KMT2AMEN1HDAC8HDAC3
SCHEMBL133683 0.84 KMT2A (0.59) ALDH1A1KMT2AHSD17B10MEN1HDAC8
SCHEMBL12134373 0.81 ALDH1A1 (0.66) ALDH1A1ACHEKMT2AHSD17B10MEN1
SCHEMBL11754615 0.81 ALDH1A1 (0.62) ALDH1A1ACHEKMT2AHSD17B10MEN1
SCHEMBL526807 0.81 KDM4E (0.68) ALDH1A1KMT2AMEN1LMNATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0768301-B1 N-(2-substituted-3-(2-aminoethyl)-1H-indol-5-yl)-amides as new 5-HT1F agonists LILLY CO ELI (US) 2003-04-02 EP disclosed
US-6126932-A INSOLUBLE POLYMER BEARING PENDANT SIDE CHAINS, SAID SIDE CHAINS EACH TERMINATING WITH THE 1-(3-(1-PYRROLIDINYL)-PROPYL)-3-ETHYLCARBODIIMIDE MOIETY. ELI LILLY AND COMPANY (US) 2000-10-03 US disclosed
EP-0994109-A2 1-(3-(1-Pyrrolidinyl)propyl)-3-ethylcarbodiimide and a solid phase coupling agent ELI LILLY AND COMPANY (US) 2000-04-19 EP disclosed
US-5998630-A A 1-(3-(1-PYRROLIDINYL)PROPY)-3-ETHYLCARBODIIMIDE ELI LILLY AND COMPANY (US) 1999-12-07 US disclosed
US-5942536-A USEFUL FOR TREATING MIGRAINE ELI LILLY AND COMPANY (US) 1999-08-24 US disclosed
US-5792763-A MIGRAINES; ANALGESICS; DISEASES LINKED TO DECREASED NEUROTRANMISSION OF SEROTONIN IN MAMMALS ELI LILLY AND COMPANY (US) 1998-08-11 US disclosed
WO-1998015545-A1 NEW SEROTONIN 5-HT1F AGONISTS ELI LILLY AND COMPANY (US) 1998-04-16 WO disclosed
EP-0835869-A2 New serotonin 5-HT1F agonists ELI LILLY AND COMPANY (US) 1998-04-15 EP disclosed
WO-1997013512-A1 N-[2-SUBSTITUTED-3-(2-AMINOETHYL)-1H-INDOL-5-YL]-AMIDES: NEW 5-HT1F AGONISTS ELI LILLY AND COMPANY (US) 1997-04-17 WO disclosed
EP-0768301-A1 N-(2-substituted-3-(2-aminoethyl)-1H-indol-5-yl)-amides as new 5-HT1F agonists ELI LILLY AND COMPANY (US) 1997-04-16 EP disclosed